ABT-888 (veliparib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-888 (veliparib), covering 2025-11-06 to 2025-11-06. Get the full timeline:
Most recent: Clinical Trial Update: ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]